Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UPFRONT-NECK: Up-front Neck Dissection in HNSCC
NCT02918955Phase 3Completed
- Sponsor
- Insel Gruppe
- Start
- Dec 2016
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in head and neck squamous cell carcinoma (HNSCC) (4 arms), sponsored by Insel Gruppe. Primary endpoint: Number of patients with acute & subacute toxicity based on CTCAE scoring system v4.03. Started Dec 2016; status: completed.
02
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT02918955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02918955.